Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017
This table browses all dspace content
Issue DateTitleJournal Title
2026Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLDCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2026First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 StudyJOURNAL OF THORACIC ONCOLOGY
2026Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final report KIDNEY RESEARCH AND CLINICAL PRACTICE
2026Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma ESMO OPEN
2026Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02ANNALS OF ONCOLOGY
2026Promising roles and current limitations of bortezomib-based desensitization for kidney transplantationKIDNEY RESEARCH AND CLINICAL PRACTICE
2026From data to policy: addressing the economic burden of biopsy-proven kidney diseases KIDNEY RESEARCH AND CLINICAL PRACTICE
2026A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis THERAPEUTIC ADVANCES IN HEMATOLOGY
2026Assessment tools for peripheral neuropathy in multiple myeloma KOREAN JOURNAL OF INTERNAL MEDICINE
2026Clinical Factors Associated With Endoscopic Decompression Failure and Recurrent Sigmoid Volvulus: A Retrospective Cohort StudyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2026Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global ConsortiumLEUKEMIA & LYMPHOMA
2026Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFR-TKI Resistance in Non-Small Cell Lung Cancer THORACIC CANCER
2026Diagnostic Value of MR Elastography and MRI-Proton Density Fat Fraction in Cirrhosis Based on Explant Liver Histology JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2026Combined effect of MASLD and low muscle strength on the risk of osteoporotic fractures: A UK Biobank cohort studyEUROPEAN JOURNAL OF ENDOCRINOLOGY
2026Evaluation of guideline adherence to hypertension-mediated organ damage screening in Korean patients with hypertension: results from the Korean Registry of Target Organ Damage in Hypertension (KorHR) CLINICAL HYPERTENSION
2026Development of Simple Assessment tool for predict imminent risk of Fracture in Elderly womenKOREAN JOURNAL OF INTERNAL MEDICINE
2026Entropy of Muscle Fiber Histology Predicts Mobility in Older Adults: The Study of Muscle, Mobility, and Aging AGING CELL
2026Associations Between Accelerometer-Measured 24-Hour Movement Behaviors and Cardiac Conduction Disease in the UK Biobank Cohort KOREAN CIRCULATION JOURNAL
2026The First Korean Clinical Evidence With Tafamidis in ATTR-CM KOREAN CIRCULATION JOURNAL
2026Severe COVID-19 in the Republic of Korea: Epidemiology, Risk Factors, Therapeutics, and Prognostic Models From Nationwide Data JOURNAL OF KOREAN MEDICAL SCIENCE

Browse

Links